In a groundbreaking study aimed at developing early, non-invasive testing methods for Parkinson’s disease, researchers have turned their attention to an unconventional source: the chemical substances secreted from the skin’s surface, including samples taken from the belly button. This innovative approach could potentially lead to significant advancements in how this neurodegenerative disorder is detected.
The research was conducted by a team at the Fraunhofer Institute in Germany, which published its findings in the journal *Scientific Reports* on September 21, 2026. The study involved collecting surface swab samples from three distinct areas of 24 participants: the nose, the areas around the ears, and the belly button. The latter site was chosen due to less interference from external factors like friction and cleaning, allowing for a more stable accumulation of local sebum and metabolites. The participants themselves included healthy individuals, as well as those diagnosed with Parkinson’s disease, mild cognitive impairment, or COVID-19.
To analyze each sample, the team utilized a technology known as photoacoustic spectroscopy. This laser-based detection method works by stimulating the samples to release gaseous molecules, which in turn generate tiny sound waves. By analyzing these sound waves, the researchers were able to identify the scent molecules present in the samples.
These scent molecules fall under the category of volatile organic compounds (VOCs). The human body continuously produces these substances, and their composition can change with the onset of diseases. Previous research has already established a link between Parkinson’s disease and alterations in the volatile organic compounds found in skin secretions.
Among the three sampling sites, the nose and belly button proved to be the most effective in distinguishing between the various groups of participants. The differences were particularly pronounced between healthy individuals and those with mild cognitive impairment. In contrast, the samples from those diagnosed with Parkinson’s disease and COVID-19 showed considerable overlap, suggesting that the current signals may still be mixed with general inflammatory or metabolic changes, which makes it difficult to pinpoint specific diseases. However, it was noted that some Parkinson’s patients, when resampled two weeks later, still exhibited the same signals correlating with their condition, indicating a certain degree of stability in these signals within individuals.
The notion that “Parkinson’s disease has a smell” originates from Joy Milne, a Scottish nurse with hereditary hyperosmia, a condition characterized by an increased sensitivity to odors. Approximately twelve years prior to her husband’s diagnosis, Milne noticed a change in his body odor, describing it as a “woody, musky smell.” Initially attributing it to regular sweat, she later recognized the same scent among other attendees at Parkinson’s support group meetings.
In a follow-up to testing her olfactory skills, scientist Tilo Kunath recruited Parkinson’s patients and healthy volunteers to wear T-shirts that had been slept in overnight. Milne successfully identified all six patients by their scent and even singled out one individual from the healthy group, who was diagnosed with Parkinson’s disease eight months later.
Kunath later admitted to National Public Radio that he was initially skeptical of Milne’s claims, struggling to understand how a disease could produce a detectable odor.
While this German study marks a promising initial step, it does not yet constitute a diagnostic test. The small sample size of just 24 participants is inadequate to support any medical application. Age also presents a confounding variable, as older individuals have different skin chemical characteristics, and both Parkinson’s disease and mild cognitive impairment become increasingly prevalent with age. The researchers emphasize the need for larger-scale studies to differentiate between changes caused by disease and those attributed to the natural aging process.
The longer-term objective is to uncover what Milne’s keen sense of smell detected in her husband years before his diagnosis. If future research substantiates these preliminary findings, the belly button could become one of the most promising areas for further examination in the quest for reliable Parkinson’s disease detection methods.